Welcome to LookChem.com Sign In|Join Free

CAS

  • or

6962-57-8

Post Buying Request

6962-57-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6962-57-8 Usage

Preparation

Preparation by Fries rearrangement of 1,4-diacetoxy- 2,6-di-methoxybenzene with aluminium chloride in nitrobenzene at r.t.

Check Digit Verification of cas no

The CAS Registry Mumber 6962-57-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,9,6 and 2 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 6962-57:
(6*6)+(5*9)+(4*6)+(3*2)+(2*5)+(1*7)=128
128 % 10 = 8
So 6962-57-8 is a valid CAS Registry Number.
InChI:InChI=1/C10H12O5/c1-5(11)8-6(12)4-7(14-2)9(13)10(8)15-3/h4,12-13H,1-3H3

6962-57-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 3,6-DIHYDROXY-2,4-DIMETHOXYACETOPHENONE

1.2 Other means of identification

Product number -
Other names 2,5-dihydroxy-4,6-dimethoxyacetophenone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6962-57-8 SDS

6962-57-8Relevant articles and documents

chromane derivatives, and pharmaceutical composition for preventing or treating neovascular eye disease or cancer containing the same as an active ingredient

-

Paragraph 0272; 0279-0282, (2020/12/01)

The invention relates to compounds of formula 1 which are chroman derivatives. The present invention provides a pharmaceutical composition for treating diseases associated with cancer or neovascularization comprising a hydrate thereof, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. Chemical Formula 1. In Chemical Formula 1 R, R represents a hydrogen atom. 1 R/R2 R/R3 R/R4 R/R5 R/R6 R/R7 As defined in the description of the invention.

Method for preparing baicalein

-

Paragraph 0014, (2017/01/12)

The invention discloses a method for preparing baicalein. According to the method, 2,6-dimethoxy-p-benzoquinone used as an initial raw material is subjected to reduction, Friedel-Crafts acetylation, claisen condensation, dehydrogenation oxidation cyclization and demethylation five reactions to obtain baicalein with high yield. The method uses low-price and easily-available initial raw material, reagent and the like, has few synthesizing steps, is easy and convenient to operate and easy for production control, has high product yield and high purity, and is suitable for large-scale preparation and production application of baicalein.

A practical and economical high-yielding, six-step sequence synthesis of a flavone: Application to the multigram-scale synthesis of ladanein

Martin-Benlloch, Xavier,Elhabiri, Mourad,Lanfranchi, Don Antoine,Davioud-Charvet, Elisabeth

, p. 613 - 617 (2014/06/09)

Herein we report a short and economic synthesis of the antiviral flavonoid lead ladanein (1). Ladanein is obtained from 2,6-dimethoxyquinone (11) in six steps with 51% overall yield. After a high-yielding reductive acetylation and Fries rearrangement, the

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6962-57-8